BR9913722A - Partìculas para fornecimento de um agente ativo aos alvéolos de um paciente humano, e método para a preparação das mesmas, método para fornecimento de um agente ativo aos pulmões de um paciente humano, e método para aumentar a quantidade de um agente ativo inalado depositado no pulmão profundo - Google Patents
Partìculas para fornecimento de um agente ativo aos alvéolos de um paciente humano, e método para a preparação das mesmas, método para fornecimento de um agente ativo aos pulmões de um paciente humano, e método para aumentar a quantidade de um agente ativo inalado depositado no pulmão profundoInfo
- Publication number
- BR9913722A BR9913722A BR9913722-4A BR9913722A BR9913722A BR 9913722 A BR9913722 A BR 9913722A BR 9913722 A BR9913722 A BR 9913722A BR 9913722 A BR9913722 A BR 9913722A
- Authority
- BR
- Brazil
- Prior art keywords
- active agent
- human patient
- delivering
- lung
- lungs
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 7
- 239000013543 active substance Substances 0.000 title abstract 6
- 210000004072 lung Anatomy 0.000 title abstract 6
- 239000002245 particle Substances 0.000 title abstract 2
- VLCQZHSMCYCDJL-UHFFFAOYSA-N tribenuron methyl Chemical compound COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)N(C)C1=NC(C)=NC(OC)=N1 VLCQZHSMCYCDJL-UHFFFAOYSA-N 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
"PARTìCULAS PARA FORNECIMENTO DE UM AGENTE ATIVO AOS ALVéOLOS DE UM PACIENTE HUMANO, E MéTODO PARA A PREPARAçãO DAS MESMAS, MéTODO PARA FORNECIMENTO DE UM AGENTE ATIVO AOS PULMõES DE UM PACIENTE HUMANO, E MéTODO PARA AUMENTAR A QUANTIDADE DE UM AGENTE ATIVO INALADO DEPOSITADO NO PULMãO PROFUNDO". A presente invenção é dirigida a composições particuladas e a métodos para o fornecimento de um ingrediente ativo ao pulmão de um paciente humano. A formulação de agente ativo está sob a forma de pó seco e exibe (i) sorção de baixa umidade, e (ii) resistência ao crescimento higroscópico, particularmente sob condições de pulmão simuladas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10016398P | 1998-09-14 | 1998-09-14 | |
| PCT/US1999/021109 WO2000015262A1 (en) | 1998-09-14 | 1999-09-13 | Dry powder active agent pulmonary delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9913722A true BR9913722A (pt) | 2001-05-29 |
Family
ID=22278404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9913722-4A BR9913722A (pt) | 1998-09-14 | 1999-09-13 | Partìculas para fornecimento de um agente ativo aos alvéolos de um paciente humano, e método para a preparação das mesmas, método para fornecimento de um agente ativo aos pulmões de um paciente humano, e método para aumentar a quantidade de um agente ativo inalado depositado no pulmão profundo |
Country Status (44)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| WO2000075281A2 (en) | 1999-06-09 | 2000-12-14 | University Technology Corporation | Supercritical fluid-assisted nebulization and bubble drying |
| US6475468B2 (en) * | 2001-02-15 | 2002-11-05 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| EP1392262A1 (en) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| EG24184A (en) | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| JP4368198B2 (ja) | 2001-11-20 | 2009-11-18 | アルカーメス，インコーポレイテッド | 肺送達用の改良された粒状組成物 |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| EA200401111A1 (ru) | 2002-02-25 | 2005-02-24 | Диффьюжн Фармасьютикалз Ллс | Биполярные соли транс-каротиноидов и их применение |
| WO2004004798A2 (en) * | 2002-07-03 | 2004-01-15 | The Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
| ATE353633T1 (de) * | 2002-12-19 | 2007-03-15 | Pharmacia Corp | Nicht-hygroskopische formulierung, die einen hygroskopischen wirkstoff enthält |
| DE10338403A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| CN101098678A (zh) | 2004-04-23 | 2008-01-02 | 锡德克斯公司 | 含有磺基烷基醚环糊精的dpi制剂 |
| MX2007010359A (es) | 2005-02-24 | 2008-04-04 | Diffusion Pharmaceuticals Llc | Trans carotenoides, su sintesis, formulacion y usos. |
| JPWO2006095788A1 (ja) * | 2005-03-09 | 2008-08-14 | 小野薬品工業株式会社 | 粒子およびその粒子を含有する製剤 |
| PL2952197T3 (pl) | 2005-10-26 | 2017-09-29 | Cydex Pharmaceuticals, Inc. | Kompozycje eteru sulfoalkilowego cyklodekstryny i sposoby ich wytwarzania |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| US20100269819A1 (en) * | 2006-08-14 | 2010-10-28 | Sievers Robert E | Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions |
| US20100093875A1 (en) * | 2006-10-25 | 2010-04-15 | Dainippon Sumitomo Pharma Co., Ltd. | Granular preparation prevented from caking |
| EP1925295A1 (de) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stabile Pulverformulierung enthaltend ein Anticholinergikum |
| CA2683760C (en) | 2007-04-13 | 2015-05-19 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| US8206751B2 (en) | 2007-10-31 | 2012-06-26 | Diffusion Pharmaceuticals Llc | Class of therapeutics that enhance small molecule diffusion |
| CN105770882A (zh) | 2009-05-20 | 2016-07-20 | Aeras全球Tb疫苗基金会 | 稳定的经喷雾干燥的免疫原性的病毒组合物 |
| US10130689B2 (en) | 2009-06-22 | 2018-11-20 | Diffusion Pharmaceuticals Llc | Diffusion enhancing compounds and their use alone or with thrombolytics |
| WO2011152869A1 (en) | 2010-06-02 | 2011-12-08 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
| CA2866230C (en) | 2012-05-03 | 2020-08-18 | Janssen R&D Ireland | Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections |
| BR112015010601B1 (pt) * | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | Composição farmacêutica e uso da composição |
| WO2015042352A1 (en) * | 2013-09-20 | 2015-03-26 | Virginia Commonwealth University | Delivery of particles using hygroscopic excipients |
| CA2965759C (en) | 2014-10-31 | 2023-12-12 | Glaxosmithkline Intellectual Property Development Limited | Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials |
| CN109152839A (zh) | 2016-03-24 | 2019-01-04 | 扩散药品有限公司 | 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途 |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155573A (en) * | 1958-05-06 | 1964-11-03 | Benger Lab Ltd | Inhalant composition and method of making same |
| CA2115065C (en) * | 1992-06-12 | 2000-10-03 | Kiyoyuki Sakon | Ultrafine particle powder for inhalation and method for production thereof |
| US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| EP0954282B1 (en) * | 1997-01-16 | 2005-01-19 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
-
1999
- 1999-09-09 MA MA25762A patent/MA25590A1/fr unknown
- 1999-09-13 YU YU24201A patent/YU24201A/sh unknown
- 1999-09-13 PL PL99346768A patent/PL195574B1/pl not_active IP Right Cessation
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 CN CN99810871A patent/CN1317977A/zh active Pending
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/en not_active Ceased
- 1999-09-13 HR HR20010189A patent/HRP20010189A2/hr not_active Application Discontinuation
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 HK HK02101738.3A patent/HK1042231A1/zh unknown
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/xx unknown
- 1999-09-13 ID IDW20010582A patent/ID28845A/id unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/en not_active Abandoned
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/ko not_active Ceased
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/sk unknown
- 1999-09-13 AR ARP990104587A patent/AR022090A1/es unknown
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/hu unknown
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/es not_active Application Discontinuation
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/ru active IP Right Revival
- 1999-09-13 EE EEP200100151A patent/EE200100151A/xx unknown
- 1999-09-13 IL IL14156299A patent/IL141562A0/xx not_active IP Right Cessation
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/es unknown
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 UA UA2001031707A patent/UA76085C2/uk unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/cs unknown
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/pt not_active IP Right Cessation
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 EP EP99969035A patent/EP1117442A1/en not_active Withdrawn
- 1999-09-13 TW TW088115876A patent/TWI226248B/zh not_active IP Right Cessation
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/xx active
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/ja not_active Withdrawn
- 1999-09-14 CO CO99058265A patent/CO5130023A1/es unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/es unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/fr unknown
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/es unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/es not_active Application Discontinuation
- 1999-10-31 SA SA99200718A patent/SA99200718B1/ar unknown
-
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/is unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/no not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/lt not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/xx unknown
- 2001-04-10 BG BG105430A patent/BG105430A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9913722A (pt) | Partìculas para fornecimento de um agente ativo aos alvéolos de um paciente humano, e método para a preparação das mesmas, método para fornecimento de um agente ativo aos pulmões de um paciente humano, e método para aumentar a quantidade de um agente ativo inalado depositado no pulmão profundo | |
| Hickey et al. | Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives | |
| DE69936268D1 (de) | Verbesserte pulverformulierungen zur inhalation | |
| PT1061901E (pt) | Inalador de nicotina | |
| DE59914603D1 (de) | Multidosis-Trockenpulverinhalator mit Pulverreservoir | |
| WO2001095874A3 (en) | Highly efficient delivery of a large therapeutic mass aerosol | |
| TR200101033T2 (tr) | Akış direnci hafifletilmiş, aerosol halindeki aktif maddenin verilmesi | |
| JO2430B1 (en) | Pharmaceutical formulas for dry powder inhalations in the form of solid pellets | |
| CA2488976A1 (en) | Inhalable epinephrine | |
| MY129384A (en) | "pharmaceutical formulations for dry powder inhalers in the form of hard-pellets" | |
| MY114665A (en) | Use of mometasone furoate for treating airway passage and lung diseases | |
| US20120042886A1 (en) | Method of producing a nicotine medicament and a medicament made by the method | |
| MXPA05009629A (es) | Composiciones que contienen trospio. | |
| Ruijgrok et al. | Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): aerosol characteristics and in-vivo amphotericin B deposition in rats | |
| DE69806362D1 (de) | Therapeutische pulverformulierung zur pulmonaren anwendung, welche kristallines insulin enthält | |
| BR0013250A (pt) | Formulações de suspensão aquosa ectoparasiticida de espinosinas | |
| EE04038B1 (et) | Inhaleeritav formoterooli sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, meetod selle valmistamiseks ning kasutamine | |
| AU5886896A (en) | Modified animal lung surfactant and its therapeutic use | |
| JPS60215092A (ja) | 人体塗布用粉末エアゾ−ル組成物 | |
| Miller et al. | Inhibition of hamster buccal pouch carcinogenesis by green coffee beans | |
| EE03950B1 (et) | Inhaleeritav terbutaliinsulfaati sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, meetod selle valmistamiseks ja kasutamine | |
| CA2265198A1 (en) | Method of producing a nicotine medicament and a medicament made by the method | |
| TH59260A3 (th) | การให้สารออกฤทธิ์ที่ได้รับการทำเป็นแอโรซอล |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1986 DE 27/03/2009. |